Cargando…
TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling
Transforming growth factor-β (TGF-β) signaling plays a key role in progression and metastasis of HCC. This study was undertaken to gain the proof of concept of a small-molecule inhibitor of TGF-β type I receptor kinase, EW-7197 as a potent anti-cancer therapy for HCC. We identified tissue inhibitors...
Autores principales: | Park, Sang-A, Kim, Min-Jin, Park, So-Yeon, Kim, Jung-Shin, Lim, Woosung, Nam, Jeong-Seok, Yhong Sheen, Yhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637930/ https://www.ncbi.nlm.nih.gov/pubmed/26549110 http://dx.doi.org/10.1038/srep16492 |
Ejemplares similares
-
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
por: Park, So-Yeon, et al.
Publicado: (2015) -
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
por: Sheen, Yhun Yhong, et al.
Publicado: (2013) -
Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
por: Park, Jiyoung, et al.
Publicado: (2022) -
Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
por: Min, Kyung Nan, et al.
Publicado: (2012) -
Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer
por: Joung, Ki Eun, et al.
Publicado: (2012)